Identification of Smyd4 as a potential tumor suppressor gene involved in breast cancer development

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Breast cancer development involves complex genetic alterations.
• Identifying key genes in tumorigenesis is crucial for understanding disease progression and developing targeted therapies.

Purpose of the Study:

• To identify genes involved in breast cancer initiation and progression.
• To investigate the role of the SET and MYND domain containing 4 (Smyd4) gene in breast tumorigenesis.

Main Methods:

• Utilized a retroviral LoxP-Cre system in mouse mammary epithelial cells (NOG8) to induce random chromosome deletions/translocations.
• Assessed Smyd4 gene expression and its functional impact on cell growth and tumor formation in vitro and in vivo.
• Employed RNA interference (RNAi) in human MCF10A cells and microarray analysis.
• Analyzed human breast cancer specimens using reverse transcription-PCR (RT-PCR).

Main Results:

• Disruption of the Smyd4 gene allele via chromosome translocation initiated tumorigenesis.
• Smyd4 expression was significantly reduced in tumor cells.
• Re-expression of Smyd4 suppressed tumor cell growth and inhibited tumor formation in mice.
• Smyd4 suppression in human cells promoted anchorage-independent growth.
• Platelet-derived growth factor receptor alpha polypeptide (Pdgfr-alpha) expression was elevated in tumor cells; Smyd4 re-expression reduced Pdgfr-alpha levels.
• Smyd4 was silenced in 2 out of 10 human breast cancer samples.

Conclusions:

• Smyd4 functions as a tumor suppressor in breast carcinogenesis.
• Smyd4 likely inhibits breast cancer progression, partly by regulating Pdgfr-alpha expression.
• Smyd4 represents a potential novel therapeutic target for breast cancer treatment.